Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > INBT Organizes Professional Development Seminar Series

Abstract:
During the summer months INBT will be organizing a series of seminars which will focus on professional development for students with an interest in nanobiotechnology. Topics that will be addressed are intellectual property, venture capital, and research ethics.

A limited number of seats are available. Interested students and/or faculty members need to send a response to Ashanti Edwards, Educational Program Coordinator for INBT, at or (410) 516 6572, or visit her in Maryland Hall 214. Seats are awarded on a first response first serve base.

Location: Maryland Hall 109
Time: 11:30AM
Date: See Description below

INBT Organizes Professional Development Seminar Series

Baltimore, MD | Posted on June 9th, 2007

Invention Protection & Licensing

Date: June 13, 2007
Subject: Intellectual Property
Presenter: Jane Kuhl

Abstract: This seminar will cover: how to properly document and report your inventions, the JHU IP policy, types of patents and licenses, negotiating licenses, typical licensing terms, patent infringement, and pursuing patent infringers. Federal regulations and JHU policies related to Hopkins inventions will be covered including how inventors can obtain rights to their inventions if they are interested in spinning-out their technology into a start-up company.

Bio: Jane Kuhl has a BS in Physics and an MS in Electrical Engineering from Georgia Institute of Technology and is currently the Director of Intellectual Property Programs for the Johns Hopkins Homewood Schools. She was Head of the Technology Transfer Office and Exhibits/Marketing groups of the US Naval Research Laboratory (NRL) in Washington DC for approximately 3 years. NRL is the Department of the Navy's corporate laboratory and has an annual research funding budget of approximately $1Billion. Before joining NRL, Jane spent more than 20 years at AT&T and its spin-offs, Lucent Technologies and Agere Systems.

Ethical Issues in Nanobiotechnology

Date(s): June 27, 2007 and July 25, 2007
Subject: Ethics in research & Case studies of biomedical ethics.
Presenter: Glenn Rahmoeller

Abstract: Ethics addresses the social concerns of technology. In this class we will learn (a) two important ethical theories and how to apply them, (b) what it means to be a professional, (c) what our professional obligations are to our employers and to society, (d) and how this all relates to our particular roles as engineers and scientists in the field of nanobiotechnology. We will discuss a specific application of nanotechnology to medicine and answer the following questions. What are the expected benefits of the technology? What are the possible risks? What are our obligations to educate society about this technology and to safeguard society from its potential harm?

Bio: Glenn Rahmoeller is a biomedical engineer with over 30 years of experience at the NIH, Director of Cardiovascular Devices at the FDA, and a consultant to the medical devices industry. He has been teaching applied ethics for university students and the medical devices industry since 1998. He is a senior lecturer in the Honors Program at the University of Maryland and a lecturer in the Department of Materials Science and Engineering at Johns Hopkins University.

Venture Capital in Nanobiotechnology

Date: July 10, 2007
Subject: Venture capital
Presenter: Justin Klein

Abstract: Through case studies we give an overview of the investment process, how you select companies/technologies, what you hope to get out of it, as well as insight into venture capitalism as a career path.

Bio: Justin Klein is a Senior Associate at New Enterprise Associates. He joined NEA's healthcare team in 2006 and focuses on medical device, biopharmaceutical, specialty pharmaceutical, and healthcare services company investments. He worked for the Duke University Health System, reporting directly to the CEO and the COO of Duke University Hospital on health system strategy, finance and clinical service unit operations. In addition, he has worked at Latham & Watkins LLP in Menlo Park, where he assisted life sciences companies on numerous licensing transactions, regulatory and corporate securities matters. Justin currently serves as a member of the Board of Trustees of Duke University, and has previously served on Duke University Medical Center's Institutional Review Board. Justin concurrently earned his MD from the Duke University School of Medicine and his JD from Harvard Law School. He received his AB in Economics and his BS in Biological Anthropology and Anatomy from Duke University.

Pending: (check back for updates)

Date: August 8, 2007
Presenter: John Schmidt

Bio: John Schmidt is Director of CBE Defense Systems at Northrop Grumman Corporation, a $30 billion global defense and technology company whose 122,000 employees provide innovative systems, products, and solutions in information and services, electronics, aerospace and shipbuilding to government and commercial customers worldwide.

####

About The Institute for NanoBioTechnology at John Hopkins University
The Institute for NanoBioTechnology at Johns Hopkins University will revolutionize health care by bringing together internationally renowned expertise in medicine, engineering, the sciences, and public health to create new knowledge and groundbreaking technologies.

INBT programs in research, education, outreach, and technology transfer are designed to foster the next wave of nanobiotechnology innovation.

Approximately 140 faculty are affiliated with INBT and are also members of the following Johns Hopkins institutions: Krieger School of Arts and Sciences, Whiting School of Engineering, School of Medicine, Bloomberg School of Public Health, and Applied Physics Laboratory.

Research at INBT is concentrated in three core areas:

* Diagnostics & Therapeutics
Research at INBT focused in this area includes biosensors, drug and gene therapy, DNA nanoparticles, functional tissue engineering, diagnostic imaging, and protein engineering.
* Health and the Environment
Research at INBT includes nano-toxicological studies, public health and environmental effects of nanotechnology, and environmental remediation using nanotechnology.
* Cellular & Molecular Dynamics
Research at INBT focused in this area includes cell signaling and interactions, molecular imaging, protein folding, and real-time visualization inside cells.

For more information, please click here

Contacts:
* Institute for NanoBioTechnology
214 Maryland Hall
3400 North Charles Street
Baltimore, MD 21218

* Email:
* Phone: (410) 516-3423
* Fax: (410) 516-2355

Copyright © John Hopkins University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Ethics

Synthetic biology needs robust safety mechanisms before real world application: Ethics and technology hold the key to the success of synthetic biology September 17th, 2015

March 2016; 6th Int'l Conference on Nanostructures in Iran July 29th, 2015

PETA science consortium to present at Society for Risk Analysis meeting December 10th, 2014

PETA science consortium experts to present at international nanotechology workshop: PETA International Science Consortium, Ltd., Is a Sponsor of Nano Risk Analysis II September 12th, 2014

Academic/Education

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

The Ottawa Hospital Research Institute uses the ZetaView from Particle Metrix to study membrane microparticles as potential biomarkers for underlying diseases April 12th, 2016

FEI Partners with Five Pharmaceutical Companies, the Medical Research Council and the University of Cambridge to form Cryo-EM Research Consortium April 5th, 2016

SUNY Poly, in Collaboration with the George Washington School of Medicine and Health Sciences and Stony Brook University, Demonstrates Pioneering Method to Visualize and Identify Engineered Nanoparticles in Tissue March 25th, 2016

Investments/IPO's/Splits

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Aspen Aerogels to Present at the 28th Annual ROTH Conference March 14th, 2016

Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016

Arrowhead to Present at Upcoming March Conferences March 1st, 2016

Announcements

Nanoparticles present sustainable way to grow food crops May 1st, 2016

Clay nanotube-biopolymer composite scaffolds for tissue engineering May 1st, 2016

Cooling graphene-based film close to pilot-scale production April 30th, 2016

Personal cooling units on the horizon April 29th, 2016

Patents/IP/Tech Transfer/Licensing

System creates on-demand 'nanotube forests,' has potential industry applications April 20th, 2016

Smaller. Cheaper. Better. Iron nitride transformers developed at Sandia could boost energy storage options March 28th, 2016

Correction: Solar fuels: Protective layer for the 'artificial leaf' March 22nd, 2016

New nanoparticle technology to decipher structure and function of membrane proteins March 9th, 2016

Events/Classes

Researchers create a first frequency comb of time-bin entangled qubits: Discovery is a significant step toward multi-channel quantum communication and higher capacity quantum computers April 28th, 2016

Introducing the RE標ORK Bio-inspired Robotics Summit in Berlin April 27th, 2016

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Team builds first quantum cascade laser on silicon: Eliminates the need for an external light source for mid-infrared silicon photonic devices or photonic circuits April 21st, 2016

Nanobiotechnology

Clay nanotube-biopolymer composite scaffolds for tissue engineering May 1st, 2016

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic